advertisement

Genetics

17 March 2011

Gene therapy: Parkinson's disease

A mid-stage trial has shown that a type of gene therapy can reduce the symptoms of advanced Parkinson's disease.

A mid-stage trial has shown that a type of gene therapy can reduce the symptoms of advanced Parkinson's disease.

In the Parkinson's trial, the delivered gene controls production of glutamic acid decarboxylase (GAD), which controls the neurotransmitter GABA.

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.